Novartis Ag (NVS) Income After Tax (2009 - 2026)
Novartis Ag (NVS) reported Income After Tax of $3.26 billion for Q2 2026, down 19.1% from $4.02 billion a year earlier and down 28.0% from the prior quarter.
Novartis Ag (NVS) Income After Tax (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Novartis Ag's Income After Tax came in at $16.27 billion, down 1.8% year-over-year; for FY2025, it was $13.97 billion, up 17.0% from FY2024.
- Income After Tax has increased for three consecutive years, with a five-year compound annual growth rate of 84.2% (FY2020 to FY2025).
- By year, Income After Tax came in at $11.94 billion in FY2024 (+20.2%), $9.94 billion in FY2023 (+64.2%), $6.05 billion in FY2022 (-73.6%) and $22.91 billion in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Income After Tax since Q2 2024.
- Year over year, Income After Tax gained in six of the last eight quarters, with growth averaging 34.0%.
- The high point for year-over-year Income After Tax in five years was Q4 2021 (growth of 482.8%); the low point was Q4 2022 (a decline of 89.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.52 billion (Q1 2026), $4.03 billion (Q4 2025) and $4.46 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,286.35 Bn | 1,259.96 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 655.58 Bn | 575.44 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 509.44 Bn | 477.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.14 Bn | 325.14 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 309.04 Bn | 282.62 Bn | - | - |
| 6 | Astrazeneca | 289.57 Bn | 263.55 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 248.97 Bn | 200.62 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.95 Bn | 182.98 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 170.25 Bn | 117.91 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Vertex Pharmaceuticals | 137.54 Bn | 109.53 Bn | 2.91 Bn | 653.60 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.26 Bn |
| Mar 31, 2026 | 4.52 Bn |
| Dec 31, 2025 | 4.03 Bn |
| Sep 30, 2025 | 4.46 Bn |
| Jun 30, 2025 | 4.02 Bn |
| Mar 31, 2025 | 5.21 Bn |
| Dec 31, 2024 | 3.75 Bn |
| Sep 30, 2024 | 3.59 Bn |
| Jun 30, 2024 | 3.25 Bn |
| Mar 31, 2024 | 3.57 Bn |
| Dec 31, 2023 | 2.12 Bn |
| Sep 30, 2023 | 1.59 Bn |
| Jun 30, 2023 | 2.27 Bn |
| Mar 31, 2023 | 2.89 Bn |
| Dec 31, 2022 | 1.82 Bn |
| Sep 30, 2022 | 1.84 Bn |
| Jun 30, 2022 | 1.70 Bn |
| Mar 31, 2022 | 3.12 Bn |
| Dec 31, 2021 | 17.60 Bn |
| Sep 30, 2021 | 3.70 Bn |
Novartis Ag Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=NVS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();